Glibenclamide Avd 5

Glibenclamide AVD 5

Country of origin - Germany
Pharm-Group - Antidiabetic agents - sulfonylurea derivatives

Manufacturers - Arzneimittelwerk Dresden GmbH (Germany)
International name - Glibenclamide
Synonyms - Antibet, Apo-Glyburide, Betanaz, Betanase, Gen-Glib, Gilemal, Glamid, Glibamid, Glibenclamide, Glibenclamide Nycomed, Glidanil, Glimidstad 1.75 Shtad, Glimidstad 3.5 Shtad, Glinil, Glucobene, Glucomid, Daonil, Diabet-control, Diabeta , Maniglid, Maninil, Ma
Dosage forms - 5 mg tablets
Composition - Active ingredient - Glibenclamide.
Indications for use - Diabetes mellitus type 2 when it is impossible to compensate for hyperglycemia with diet, weight loss, and physical activity.
Contraindications - Hypersensitivity (including to sulfonamide drugs, thiazade diuretics), diabetic precomatose and comatose state, ketoacidosis, extensive burns, surgery and trauma, intestinal obstruction, gastric paresis; conditions accompanied by impaired absorption of food, the development of hypoglycemia (infectious diseases, etc.); hypo- or hyperthyroidism, impaired liver and kidney function, leukopenia, type 1 diabetes mellitus, pregnancy, breastfeeding.
Side effects - Hypoglycemia, changes in the blood, nervous system, liver, gastrointestinal tract. Allergic reactions.
Interaction - Enhance the hypoglycemic effect: antifungals, antibiotics, NSAIDs, ACE inhibitors, insulin. Weaken the effect: hormones, diuretics, sympathomimetics.
Overdose - Hypoglycemia, coma.
Special instructions - Maintain regular intake, monitor glucose levels. Avoid alcohol, sun, fatty foods.